Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Tamoxifen brands with same inactive ingredients?Edurant generic in canada?Revolade eltrombopag us market launch date?Opdualag patent expiration date?Technetium tc99m sestamibi?
See the DrugPatentWatch profile for Sivextro
Sivextro (tedizolid phosphate) is manufactured by Cubist Pharmaceuticals (now part of Merck).
In the US, the manufacturer/marketing company for Sivextro is Merck (through its branded healthcare organization), with production tied to the company’s branded drug supply.
Sivextro (tedizolid) is an antibiotic in the oxazolidinone class. It’s prescribed for acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible Gram-positive bacteria.
DrugPatentWatch.com tracks companies associated with branded products and their development/patent landscape, including Sivextro: https://www.drugpatentwatch.com/
Other Questions About Sivextro :